CERSのチャート
CERSの企業情報
| symbol | CERS |
|---|---|
| 会社名 | Cerus Corp. （シ―ラス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 シーラス(Cerus Corporation)は生物医学製品会社であり、血液の安全性を高めるために自社の「インターセプト・ブラッド・システム(INTERCEPT Blood System)」の商業化を中心に事業を展開する。同社は、血液安全セグメントを通じて事業を行う。同社のINTERCEPT血液システムは、生物学的複製を制御する技術に基づいて、輸血を目的とする寄贈血液成分中の血液媒介病原体を減少させるように設計される。同社のINTERCEPT血液システムは、ヒト免疫不全ウイルス（HIV）、西ナイル病、重症急性呼吸器症候群（SARS）、B型肝炎・C型肝炎、細菌や寄生虫を含むウイルスなどの血液媒介病原体を標的とし、それらを不活性化するように設計される 血小板、血漿及び赤血球輸血製品の治療特性を保持しながら、有害な白血球として使用できる。同社のINTERCEPT血液システムは、血漿、血小板及び赤血球などの血液成分とともに使用される。 シ―ラスは米国の生物医学的製品企業。血液の安全性を高めるためのシステム「インタ―セプト・ブラッド・システム」を開発。献血血液成分中にある血液媒介病原体を不活性化させる。同システムは欧州、独立国家共同体、中東、その他の国々の血液銀行、病院、大学や政府機関に直接販売される。本社はカリフォルニア州。 Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. |
| 本社所在地 | 2550 Stanwell Dr. Concord CA 94520 USA |
| 代表者氏名 | Daniel N. Swisher ダニエル・N・スウィッシャー |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 925-288-6000 |
| 設立年月日 | 33482 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 1997年 |
| 従業員数 | 215人 |
| url | www.cerus.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cers |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -47.46400 |
| 終値（lastsale） | 6.3 |
| 時価総額（marketcap） | 843027544.8 |
| 時価総額 | 時価総額（百万ドル） 887.18620 |
| 売上高 | 売上高（百万ドル） 68.18600 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 805.11020 |
| 当期純利益 | 当期純利益（百万ドル） -52.07100 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Cerus Corporation revenues increased 86% to $36.5M. Net loss decreased 24% to $27.2M. Revenues reflect Revenue increase of 75% to $29M Government contracts revenue increase from $3.1M to $7.5M. Lower net loss reflects Foreign exchange loss decrease of 49% to $30K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.34 to -$0.21. |
CERSのテクニカル分析
CERSのニュース
Cerus Corporation (NASDAQ: CERS): The Stock We Should Bet On For Economic Growth In The Months To Come 2023/02/08 16:00:00 Marketing Sentinel
In the last trading session, 1.1 million shares of the Cerus Corporation (NASDAQ:CERS) were traded, and its beta was 0.98. Most recently the company’s share price was $3.21, and it changed around $0.01 or 0.31% from the last close, which brings the market valuation of the company to $585.31M. CERS currently trades at a discount … Cerus Corporation (NASDAQ: CERS): The Stock We Should Bet On For Economic Growth In The Months To Come Read More »
Cerus Corporation (NASDAQ: CERS)’s 4.17-Percent Gain Of This Past Week Taught Us Something New 2023/02/04 16:00:00 Marketing Sentinel
Cerus Corporation (NASDAQ:CERS)’s traded shares stood at 1.83 million during the last session, with the company’s beta value hitting 0.97. At the close of trading, the stock’s price was $3.25, to imply a decrease of -2.69% or -$0.09 in intraday trading. The CERS share’s 52-week high remains $6.00, putting it -84.62% down since that peak … Cerus Corporation (NASDAQ: CERS)’s 4.17-Percent Gain Of This Past Week Taught Us Something New Read More »
Cerus: Unable To Catch A Reasonable Bid Since FY23E Guidance (NASDAQ:CERS) 2023/02/03 18:30:00 Seeking Alpha
Cerus pushed below its longer-term support level after issuing FY23E guidance in January. Click here to read why I reiterate our Hold rating on CERS stock.
Do investors need to be concerned about Cerus Corporation (CERS)? 2023/02/01 15:24:00 US Post News
Cerus Corporation (NASDAQ:CERS) marked $3.14 per share on Tuesday, up from a previous closing price of $3.01. While Cerus Corporation has overperformed by 4.32%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -37.57%, with highs and lows ranging from $6.00 to $2.53, whereas […]
Cerus Corporation (NASDAQ: CERS) Stock Dropped -22.89% Over A Month – Are There Any Chances Of Growth? 2023/01/20 18:00:00 Marketing Sentinel
During the recent session, Cerus Corporation (NASDAQ:CERS)’s traded shares were 0.68 million, with the beta value of the company hitting 1.01. At the last check today, the stock’s price was $3.09, reflecting an intraday loss of -0.32% or -$0.01. The 52-week high for the CERS share is $6.00, that puts it down -94.17 from that … Cerus Corporation (NASDAQ: CERS) Stock Dropped -22.89% Over A Month – Are There Any Chances Of Growth? Read More »
Cerus Corporation (CERS) is an excellent investment, but the stock is overvalued/undervalued right now 2022/12/30 14:16:00 US Post News
A share of Cerus Corporation (NASDAQ:CERS) closed at $3.57 per share on Thursday, up from $3.43 day before. While Cerus Corporation has overperformed by 4.08%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -47.65%, with highs and lows ranging from $7.08 to $3.25, […]
Cerus Corporation (CERS) did well last session? 2022/12/02 16:00:00 US Post News
As of Thursday, Cerus Corporation’s (NASDAQ:CERS) stock closed at $4.13, up from $4.00 the previous day. While Cerus Corporation has overperformed by 3.25%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -38.45%, with highs and lows ranging from $7.20 to $3.25, whereas the […]
CERS (Cerus Corporation) has impressive results 2022/11/25 16:08:00 US Post News
In Wednesday’s session, Cerus Corporation (NASDAQ:CERS) marked $3.91 per share, up from $3.82 in the previous session. While Cerus Corporation has overperformed by 2.36%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -45.01%, with highs and lows ranging from $7.20 to $3.25, whereas […]
Cerus''s Return On Capital Employed Overview 2022/11/21 14:48:30 Benzinga
Benzinga Pro data, Cerus (NASDAQ: CERS ) reported Q3 sales of $39.57 million. Earnings fell to a loss of $8.52 million, resulting in a 1.5% decrease from last quarter. Cerus collected $41.00 million in revenue during Q2, but reported earnings showed a $8.39 million loss. Why Is ROCE Significant? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a … Full story available on Benzinga.com
Results from Cerus Corporation (CERS) show risk 2022/11/18 13:16:00 US Post News
In Thursday’s session, Cerus Corporation (NASDAQ:CERS) marked $3.84 per share, down from $3.95 in the previous session. While Cerus Corporation has underperformed by -2.78%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -47.33%, with highs and lows ranging from $7.36 to $3.25, whereas […]
Cerus Corporation (CERS) did well last session? 2022/12/02 16:00:00 US Post News
As of Thursday, Cerus Corporation’s (NASDAQ:CERS) stock closed at $4.13, up from $4.00 the previous day. While Cerus Corporation has overperformed by 3.25%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -38.45%, with highs and lows ranging from $7.20 to $3.25, whereas the […]
CERS (Cerus Corporation) has impressive results 2022/11/25 16:08:00 US Post News
In Wednesday’s session, Cerus Corporation (NASDAQ:CERS) marked $3.91 per share, up from $3.82 in the previous session. While Cerus Corporation has overperformed by 2.36%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -45.01%, with highs and lows ranging from $7.20 to $3.25, whereas […]
Cerus''s Return On Capital Employed Overview 2022/11/21 14:48:30 Benzinga
Benzinga Pro data, Cerus (NASDAQ: CERS ) reported Q3 sales of $39.57 million. Earnings fell to a loss of $8.52 million, resulting in a 1.5% decrease from last quarter. Cerus collected $41.00 million in revenue during Q2, but reported earnings showed a $8.39 million loss. Why Is ROCE Significant? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a … Full story available on Benzinga.com
Results from Cerus Corporation (CERS) show risk 2022/11/18 13:16:00 US Post News
In Thursday’s session, Cerus Corporation (NASDAQ:CERS) marked $3.84 per share, down from $3.95 in the previous session. While Cerus Corporation has underperformed by -2.78%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -47.33%, with highs and lows ranging from $7.36 to $3.25, whereas […]
Was anything negative for Cerus Corporation (CERS) stock last session? 2022/11/10 16:16:00 US Post News
The share price of Cerus Corporation (NASDAQ:CERS) fell to $3.58 per share on Wednesday from $3.70. While Cerus Corporation has underperformed by -3.24%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CERS fell by -52.27%, with highs and lows ranging from $7.79 to $3.25, whereas the […]